Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

USP18 Impacts Cisplatin Resistance in Ovarian Cancer Cells by Modulating DNA Repair.

International journal of biological sciences·2026
Same author

LINE-1 Deregulation in Ovarian Cancer: Implications for Diagnosis, Prognosis, and Therapeutic Targeting.

Molecular diagnosis & therapy·2026
Same author

Exploring bone formation mechanism and pattern during RANKL inhibition in a fibrous dysplasia mouse model.

Communications biology·2026
Same author

Examining Genetic Variants Associated with FOXP1 Syndrome through Molecular Dynamics of Its DNA-Binding Domain and Self-Organizing Maps.

Journal of chemical information and modeling·2026
Same author

Bioinformatic and computational biophysics tools for nanopore engineering: a review from standard approaches to machine learning advancements.

Journal of nanobiotechnology·2026
Same author

Prolyl-isomerase Pin1 drives platinum resistance by regulating Notch3 stability and function in ovarian cancer.

Journal of experimental & clinical cancer research : CR·2026

Related Experiment Video

Updated: May 20, 2025

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.1K

Peptidomimetics design and characterization: Bridging experimental and computer-based approaches.

Alice Romagnoli1, Jesmina Rexha1, Nunzio Perta1

  • 1Department of Life and Environmental Sciences, Polytechnic University of Marche, Ancona, Italy; New York-Marche Structural Biology Centre (NY-MaSBiC), Polytechnic University of Marche, Ancona, Italy; Neuronal Death and Neuroprotection Unit, Department of Neuroscience, Mario Negri Institute for Pharmacological Research-IRCCS, Milan, Italy.

Progress in Molecular Biology and Translational Science
|March 23, 2025
PubMed
Summary

Peptidomimetics offer improved drug properties, enhancing delivery and specificity for treating diseases by targeting protein-protein interactions. These advanced molecules represent a promising frontier in precision drug discovery and development.

Keywords:
Computational approachesDrug designPPI inhibitorsPeptide modificationsPeptide-based therapyPeptidomimetics

More Related Videos

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.0K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Related Experiment Videos

Last Updated: May 20, 2025

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library
13:37

Split-and-pool Synthesis and Characterization of Peptide Tertiary Amide Library

Published on: June 20, 2014

18.1K
Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions
06:50

Author Spotlight: A Computational Approach to Decipher Amino Acid Preferences in Multispecific Protein-Protein Interactions

Published on: January 26, 2024

1.0K
Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
10:33

Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors

Published on: October 26, 2015

11.3K

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Biochemistry

Background:

  • Peptidomimetics mimic peptide biological activity with enhanced drug-like properties.
  • They offer advantages over native peptides, including improved delivery, cell penetration, target specificity, and protease resistance.
  • Peptidomimetics are crucial for addressing protein-protein interactions (PPIs) implicated in various diseases.

Purpose of the Study:

  • To provide a comprehensive overview of peptidomimetics in drug design.
  • To explore their role in pathologies, chemical strategies, and characterization methodologies.
  • To highlight their potential in revolutionizing therapeutic approaches and precision drug discovery.

Main Methods:

  • Utilizing structural biology and computational methods (e.g., molecular dynamics simulations) for rational design.
  • Employing machine learning algorithms for accelerated protein structure prediction.
  • Conducting experimental validation through spectroscopic, biophysical, and biochemical assays.

Main Results:

  • Peptidomimetics demonstrate significant potential in treating diverse diseases like cancer and neurodegenerative disorders.
  • Their tailored constrained structures are effective in targeting disturbed protein-protein interactions.
  • Numerous peptidomimetics are currently in clinical trials or development.

Conclusions:

  • Peptidomimetics represent a frontier in drug design, particularly for targeting PPIs.
  • Integrated computational and experimental approaches facilitate efficient peptidomimetic development.
  • The growing pharmaceutical interest underscores their promise for a new era of precision therapeutics.